Financials
- Market Capitalization 2.06 B
- Employee 562
- Founded 2012
- CEO Carl Hansen
- Website www.abcellera.com
- Headquarter British Columbia, Canada
- FIGI BBG00LLW2MF2
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 1962 | SNDX Syndax Pharmaceuticals, Inc. - Common Stock | 23.52 USD | -2.53% | -5.05% | +25.98% | +154.00% | 2.08 B USD | ||
| 1968 | AUPH Aurinia Pharmaceuticals Inc - Common Shares | 16.10 USD | +0.75% | -1.77% | -0.74% | +34.95% | 2.07 B USD | ||
| 1977 | NUVB Nuvation Bio Inc. Class A Common Stock | 5.89 USD | -0.17% | -0.67% | +14.15% | +162.95% | 2.05 B USD | ||
| 1990 | HRMY Harmony Biosciences Holdings, Inc. - Common Stock | 34.90 USD | +0.26% | -8.06% | +3.56% | +12.94% | 2.02 B USD |
Frequently asked questions about AbCellera Biologics Inc. - Common Shares
What is the AbCellera Biologics Inc. - Common Shares stock price today?
The current price of AbCellera Biologics Inc. - Common Shares (ABCL) is 6.74. Over the past 24 hours, the stock has changed by 0.00%. Follow the ABCL chart for real-time price dynamics.
What is the stock ticker of AbCellera Biologics Inc. - Common Shares?
AbCellera Biologics Inc. - Common Shares trades under the ticker ABCL. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is AbCellera Biologics Inc. - Common Shares stock going up?
ABCL has changed by -3.85% over the last week, +30.12% over the last month, and +64.39% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was AbCellera Biologics Inc. - Common Shares net income for the last quarter?
AbCellera Biologics Inc. - Common Shares reported net income of -43.16 M for the last quarter. The previous quarter showed -8.95 M, which means net income changed by -382.56%.
How many employees does AbCellera Biologics Inc. - Common Shares have?
As of the latest available data, AbCellera Biologics Inc. - Common Shares has 562 employees. Workforce size can provide additional context about the company's scale and operations.
What is AbCellera Biologics Inc. - Common Shares EBITDA?
AbCellera Biologics Inc. - Common Shares EBITDA is -50.68 M, and its EBITDA margin is -609.51%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy AbCellera Biologics Inc. - Common Shares stock?
You can buy AbCellera Biologics Inc. - Common Shares (ABCL) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in AbCellera Biologics Inc. - Common Shares stock?
Investing in AbCellera Biologics Inc. - Common Shares requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the ABCL chart and related analysis on metatrader.com as part of your research.